SLC5A5 and differentiated thyroid carcinoma: Recent progress in understanding the molecular mechanisms that repress functional NIS expression has brought about possibilities of new therapeutic approaches to enhance radioiodide accumulation in radioiodide-refractory differentiated thyroid cancer metastasis [26,43,44].